Cellular Senescence: A Translational Perspective

EBioMedicine

Volumn 21, Issue , 2017, Pages 21-28

  Kirkland, James L ^a   Tchkonia, Tamara ^a  

^a MAYO CLINIC   (United States)

Author keywords

A1155463; A1331852; Dasatinib; Fisetin; Navitoclax; Quercetin; SASP inhibitors; Senescent Cell Anti apoptotic Pathways (SCAPs); Senolytics

Indexed keywords

ANTIMITOTIC AGENT; BIOLOGICAL MARKER;

ACHILLES REFLEX; AGING; APOPTOSIS; BIOACCUMULATION; CELL FUNCTION; GERIATRIC DISORDER; HUMAN; METABOLIC BALANCE; MOLECULARLY TARGETED THERAPY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSYCHOLOGICAL RESILIENCE; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; STEM CELL; TRANSLATIONAL RESEARCH; ANIMAL; ANIMAL EXPERIMENT; CELL AGING; CHRONIC DISEASE; DISEASE PREDISPOSITION; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; PHYSIOLOGY; SECRETORY PATHWAY;

AGING; ANIMAL EXPERIMENTATION; ANIMALS; APOPTOSIS; BIOMARKERS; CELLULAR SENESCENCE; CHRONIC DISEASE; DISEASE SUSCEPTIBILITY; DRUG DISCOVERY; HUMANS; PHENOTYPE; SECRETORY PATHWAY; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85017444050     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2017.04.013     Document Type: Review

References (64)

1. Austad, S.N., Bartke, A., Sex differences in longevity and in responses to anti-aging interventions: a mini-review. Gerontology 62 (2015), 40–46.
2. Baar, M.P., Brandt, R.M., Putavet, D.A., Klein, J.D., Derks, K.W., Bourgeois, B.R., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D.A., van der Pluijm, I., Essers, J., van Cappellen, W.A., Van, I.W.F., Houtsmuller, A.B., Pothof, J., de Bruin, R.W., Madl, T., Hoeijmakers, J.H., Campisi, J., de Keizer, P.L., Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell, 169(132–147), 2017, e16.
3. Baker, D.J., Childs, B.G., Durik, M., Wijers, M.E., Sieben, C.J., Zhong, J., Saltness, R.A., Jeganathan, K.B., Verzosa, G.C., Pezeshki, A., Khazaie, K., Miller, J.D., van Deursen, J.M., Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530 (2016), 184–189.
4. Baker, D.J., Wijshake, T., Tchkonia, T., Lebrasseur, N.K., Childs, B.G., van de Sluis, B., Kirkland, J.L., van Deursen, J.M., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (2011), 232–236.
5. Bannister, C.A., Holden, S.E., Jenkins-Jones, S., Morgan, C.L., Halcox, J.P., Schernthaner, G., Mukherjee, J., Currie, C.J., Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes. Metab. 16 (2014), 1165–1173.
6. Bitto, A., Ito, T.K., Pineda, V.V., Letexier, N.J., Huang, H.Z., Sutlief, E., Tung, H., Vizzini, N., Chen, B., Smith, K., Meza, D., Yajima, M., Beyer, R.P., Kerr, K.F., Davis, D.J., Gillespie, C.H., Snyder, J.M., Treuting, P.M., Kaeberlein, M., Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice. Elife, 2016, 5.
7. BURD, C.E., GILL, M.S., NIEDERNHOFER, L.J., ROBBINS, P.D., AUSTAD, S.N., BARZILAI, N., KIRKLAND, J.L., Barriers to the preclinical development of therapeutics that target aging mechanisms. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 71 (2016), 1388–1394.
8. Chaikriangkrai, K., Jhun, H.Y., Palamaner Subash Shantha, G., Bin Abdulhak, A., Sigurdsson, G., Nabi, F., Mahmarian, J.J., Chang, S.M., Coronary artery calcium score as a predictor for incident stroke: systematic review and meta-analysis. Int. J. Cardiol., 2017, 10.1016/j.ijcard.2017.01.132 (Feb 8. pii: S0167-5273(17)30060-8. Epub ahead of print).
9. Chang, J., Wang, Y., Shao, L., Laberge, R.M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N.E., Ding, S., Feng, W., Luo, Y., Wang, X., Aykin-Burns, N., Krager, K., Ponnappan, U., Hauer-Jensen, M., Meng, A., Zhou, D., Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22 (2016), 78–83.
10. Childs, B.G., Baker, D.J., Wijshake, T., Conover, C.A., Campisi, J., van Deursen, J.M., Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354 (2016), 472–477.
11. Coppé J.P., Kauser, K., Campisi, J., Beauséjour, C.M., Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J. Biol. Chem. 281 (2006), 29568–29574.
12. Demaria, M., Ohtani, N., Youssef, S.A., Rodier, F., Toussaint, W., Mitchell, J.R., Laberge, R.M., Vijg, J., van Steeg, H., Dolle, M.E., Hoeijmakers, J.H., de Bruin, A., Hara, E., Campisi, J., An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31 (2014), 722–733.
13. Goldman, D.P., Cutler, D., Rowe, J.W., Michaud, P.C., Sullivan, J., Peneva, D., Olshansky, S.J., Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff. 32 (2013), 1698–1705.
14. Hall, B.M., Balan, V., Gleiberman, A.S., Strom, E., Krasnov, P., Virtuoso, L.P., Rydkina, E., Vujcic, S., Balan, K., Gitlin, I., Leonova, K., Polinsky, A., Chernova, O.B., Gudkov, A.V., Aging of mice is associated with p16(Ink4a)- and beta-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells. Aging 8 (2016), 1294–1315.
15. Harrison, D.E., Strong, R., Sharp, Z.D., Nelson, J.F., Astle, C.M., Flurkey, K., Nadon, N.L., Wilkinson, J.E., Frenkel, K., Carter, C.S., Pahor, M., Javors, M.A., Fernandez, E., Miller, R.A., Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460 (2009), 392–395.
16. Hewitt, G., Jurk, D., Marques, F.D., Correia-Melo, C., Hardy, T., Gackowska, A., Anderson, R., Taschuk, M., Mann, J., Passos, J.F., Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun., 3, 2012, 708.
17. Huffman, D.M., Justice, J.N., Stout, M.B., Kirkland, J.L., Barzilai, N., Austad, S.N., Evaluating health span in preclinical models of aging and disease: guidelines, challenges, and opportunities for geroscience. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 71 (2016), 1395–1406.
18. Jurk, D., Wilson, C., Passos, J.F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., Hewitt, G., Pender, S.L., Fullard, N., Nelson, G., Mann, J., van de Sluis, B., Mann, D.A., Von Zglinicki, T., Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun., 2, 2014, 4172.
19. Justice, J., Miller, J.D., Newman, J.C., Hashmi, S.K., Halter, J., Austad, S.N., Barzilai, N., Kirkland, J.L., Frameworks for proof-of-concept clinical trials of interventions that target fundamental aging processes. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 71 (2016), 1415–1423.
20. Kirkland, J.L., Translating advances from the basic biology of aging into clinical application. Exp. Gerontol. 48 (2013), 1–5.
21. Kirkland, J.L., Translating the science of aging into therapeuticiInterventions. Cold Spring Harbor Perspect. Med., 6, 2016, a025908.
22. Kirkland, J.L., Peterson, C., Healthspan, translation, and new outcomes for animal studies of aging. J. Gerontol. A Biol. Sci. Med. Sci. 64 (2009), 209–212.
23. Kirkland, J.L., Stout, M.B., Sierra, F., Resilience in aging mice. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 71 (2016), 1407–1414.
24. Kirkland, J.L., Tchkonia, T., Clinical strategies and animal models for developing senolytic agents. Exp. Gerontol. 68 (2015), 19–25.
25. Krishnamurthy, J., Torrice, C., Ramsey, M.R., Kovalev, G.I., Al-Regaiey, K., Su, L., Sharpless, N.E., Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114 (2004), 1299–1307.
26. Laberge, R.M., Sun, Y., Orjalo, A.V., Patil, C.K., Freund, A., Zhou, L., Curran, S.C., Davalos, A.R., Wilson-Edell, K.A., Liu, S., Limbad, C., Demaria, M., Li, P., Hubbard, G.B., Ikeno, Y., Javors, M., Desprez, P.Y., Benz, C.C., Kapahi, P., Nelson, P.S., Campisi, J., MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol. 17 (2015), 1049–1061.
27. Laberge, R.M., Zhou, L., Sarantos, M.R., Rodier, F., Freund, A., de Keizer, P.L., Liu, S., Demaria, M., Cong, Y.S., Kapahi, P., Desprez, P.Y., Hughes, R.E., Campisi, J., Glucocorticoids suppress selected components of the senescence-associated secretory phenotype. Aging Cell 11 (2012), 569–578.
28. Lamming, D.W., Ye, L., Katajisto, P., Goncalves, M.D., Saitoh, M., Stevens, D.M., Davis, J.G., Salmon, A.B., Richardson, A., Ahima, R.S., Guertin, D.A., Sabatini, D.M., Baur, J.A., Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335 (2012), 1638–1643.
29. Lanzer, P., Boehm, M., Sorribas, V., Thiriet, M., Janzen, J., Zeller, T., St Hilaire, C. & Shanahan, C., Medial vascular calcification revisited: review and perspectives. Eur. Heart J. 35 (2014), 1515–1525.
30. Lebrasseur, N.K., Tchkonia, T., Kirkland, J.L., Cellular Senescence and the Biology of Aging, Disease, and Frailty. Nestle Nutrition Institute workshop series, vol. 83, 2015, 11–18.
31. Leverson, J.D., Phillips, D.C., Mitten, M.J., Boghaert, E.R., Diaz, D., Tahir, S.K., Belmont, L.D., Nimmer, P., Xiao, Y., Ma, X.M., Lowes, K.N., Kovar, P., Chen, J., Jin, S., Smith, M., Xue, J., Zhang, H., Oleksijew, A., Magoc, T.J., Vaidya, K.S., Albert, D.H., Tarrant, J.M., LA, N., Wang, L., Tao, Z.F., Wendt, M.D., Sampath, D., Rosenberg, S.H., Tse, C., Huang, D.C., Fairbrother, W.J., Elmore, S.W., Souers, A.J., Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. Sci. Transl. Med., 7, 2015, 279ra40.
32. Li, J., Kim, S.G., Blenis, J., Rapamycin: one drug, many effects. Cell Metab. 19 (2014), 373–379.
33. Majumder, S., Caccamo, A., Medina, D.X., Benavides, A.D., Javors, M.A., Kraig, E., Strong, R., Richardson, A., Oddo, S., Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling. Aging Cell 11 (2012), 326–335.
34. Mannick, J.B., Del Giudice, G., Lattanzi, M., Valiante, N.M., Praestgaard, J., Huang, B., Lonetto, M.A., Maecker, H.T., Kovarik, J., Carson, S., Glass, D.J., Klickstein, L.B., mTOR inhibition improves immune function in the elderly. Sci. Transl. Med., 6, 2014, 268ra179.
35. Minamino, T., Orimo, M., Shimizu, I., Kunieda, T., Yokoyama, M., Ito, T., Nojima, A., Nabetani, A., Oike, Y., Matsubara, H., Ishikawa, F., Komuro, I., A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15 (2009), 1082–1087.
36. Moiseeva, O., Deschenes-Simard, X., St-Germain, E., Igelmann, S., Huot, G., Cadar, A.E., Bourdeau, V., Pollak, M.N., Ferbeyre, G., Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-kappaB activation. Aging Cell 12 (2013), 489–498.
37. Newman, J.C., Milman, S., Hashmi, S.K., Austad, S.N., Kirkland, J.L., Halter, J.B., Barzilai, N., Strategies and challenges in clinical trials targeting human aging. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 71 (2016), 1424–1434.
38. Passos, J.F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C.J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., Saretzki, G., Rudolph, K.L., Kirkwood, T.B., von Zglinicki, T., Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol., 6, 2010, 347.
39. Passos, J.F., Saretzki, G., Ahmed, S., Nelson, G., Richter, T., Peters, H., Wappler, I., Birket, M.J., Harold, G., Schaeuble, K., Birch-Machin, M.A., Kirkwood, T.B., von Zglinicki, T., Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol., 5, 2007, e110.
40. Roos, C.M., Zhang, B., Palmer, A.K., Ogrodnik, M.B., Pirtskhalava, T., Thalji, N.M., Hagler, M., Jurk, D., Smith, L.A., Casaclang-Verzosa, G., Zhu, Y., Schafer, M.J., Tchkonia, T., Kirkland, J.L., Miller, J.D., Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell, 2016 Feb 10 http://dx.doi.org/10.1111/acel.12458 (Epub ahead of print).
41. Schafer, M.J., White, T.A., Evans, G., Tonne, J.M., Verzosa, G.C., Stout, M.B., Mazula, D.L., Palmer, A.K., Baker, D.J., Jensen, M.D., Torbenson, M.S., Miller, J.D., Ikeda, Y., Tchkonia, T., van Deursen, J.M., Kirkland, J.L., Lebrasseur, N.K., Exercise prevents diet-induced cellular senescence in adipose tissue. Diabetes, 2016.
42. Schafer, M.J., White, T.A., Iijima, K., Haak, A.J., Ligresti, G., Atkinson, E.J., Oberg, A.L., Birch, J., Salmonowicz, H., Zhu, Y., Mazula, D.L., Brooks, R.W., Fuhrmann-Stroissnigg, H., Pirtskhalava, T., Prakash, Y.S., Tchkonia, T., Robbins, P.D., Aubry, M.C., Passos, J.F., Kirkland, J.L., Tschumperlin, D.J., Kita, H., Lebrasseur, N.K., Cellular senescence mediates fibrotic pulmonary disease. Nat. Commun., 8, 2017, 14532.
43. St Sauver, J.L., Boyd, C.M., Grossardt, B.R., Bobo, W.V., Finney Rutten, L.J., Roger, V.L., Ebbert, J.O., Therneau, T.M., Yawn, B.P., Rocca, W.A., Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open, 5, 2015, e006413.
44. Stoneman, V., Braganza, D., Figg, N., Mercer, J., Lang, R., Goddard, M., Bennett, M., Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 100 (2007), 884–893.
45. Stout, M.B., Steyn, F.J., Jurczak, M.J., Camporez, J.G., Zhu, Y., Hawse, J.R., Jurk, D., Palmer, A.K., Xu, M., Pirtskhalava, T., Evans, G.L., de Souza Santos, R., Frank, A.P., White, T.A., Monroe, D.G., Singh, R.J., Casaclang-Verzosa, G., Miller, J.D., Clegg, D.J., Lebrasseur, N.K., Von Zglinicki, T., Shulman, G.I., Tchkonia, T., Kirkland, J.L., 17alpha-estradiol alleviates age-related metabolic and inflammatory dysfunction in male mice without inducing feminization. J. Gerontol. A Biol. Sci. Med. Sci., 2016 (Jan 24. pii: glv309. Epub ahead of print).
46. Stout, M.B., Tchkonia, T., Pirtskhalava, T., Palmer, A.K., List, E.O., Berryman, D.E., Lubbers, E.R., Escande, C., Spong, A., Masternak, M.M., Oberg, A.L., Lebrasseur, N.K., Miller, R.A., Kopchick, J.J., Bartke, A., Kirkland, J.L., Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice. Aging 6 (2014), 575–586.
47. Strong, R., Miller, R.A., Antebi, A., Astle, C.M., Bogue, M., Denzel, M.S., Fernandez, E., Flurkey, K., Hamilton, K.L., Lamming, D.W., Javors, M.A., de Magalhaes, J.P., Martinez, P.A., Mccord, J.M., Miller, B.F., Muller, M., Nelson, J.F., Ndukum, J., Rainger, G.E., Richardson, A., Sabatini, D.M., Salmon, A.B., Simpkins, J.W., Steegenga, W.T., Nadon, N.L., Harrison, D.E., Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an alpha-glucosidase inhibitor or a Nrf2-inducer. Aging Cell 15 (2016), 872–884.
48. Tchkonia, T., Morbeck, D.E., von Zglinicki, T., van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M.D., Kirkland, J.L., Fat tissue, aging, and cellular senescence. Aging Cell 9 (2010), 667–684.
49. Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., Kirkland, J.L., Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 123 (2013), 966–972.
50. Tran, D., Bergholz, J., Zhang, H., He, H., Wang, Y., Zhang, Y., Li, Q., Kirkland, J.L., Xiao, Z.X., Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging Cell 13 (2014), 669–678.
51. Verstovsek, S., Kantarjian, H., Mesa, R.A., Pardanani, A.D., Cortes-Franco, J., Thomas, D.A., Estrov, Z., Fridman, J.S., Bradley, E.C., Erickson-Viitanen, S., Vaddi, K., Levy, R., Tefferi, A., Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. N. Engl. J. Med. 363 (2010), 1117–1127.
52. Wang, E., Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 55 (1995), 2284–2292.
53. Wang, Y., Chang, J., Liu, X., Zhang, X., Zhang, S., Zhou, D., Zheng, G., Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Aging 8 (2016), 2915–2926.
54. Wiley, C.D., Velarde, M.C., Lecot, P., Liu, S., Sarnoski, E.A., Freund, A., Shirakawa, K., Lim, H.W., Davis, S.S., Ramanathan, A., Gerencser, A.A., Verdin, E., Campisi, J., Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23 (2016), 303–314.
55. Wilkinson, J.E., Burmeister, L., Brooks, S.V., Chan, C.C., Friedline, S., Harrison, D.E., Hejtmancik, J.F., Nadon, N., Strong, R., Wood, L.K., Woodward, M.A., Miller, R.A., Rapamycin slows aging in mice. Aging Cell 11 (2012), 675–682.
56. Xu, M., Bradley, E.W., Weivoda, M.M., Hwang, S.M., Pirtskhalava, T., Decklever, T., Curran, G.L., Ogrodnik, M., Jurk, D., Johnson, K.O., Lowe, V., Tchkonia, T., Westendorf, J.J., Kirkland, J.L., Transplanted senescent cells induce an osteoarthritis-like condition in mice. J. Gerontol. Ser. A Biol. Sci. Med. Sci., 2016 (Aug 10. pii: glw154. Epub ahead of print).
57. Xu, M., Palmer, A.K., Ding, H., Weivoda, M.M., Pirtskhalava, T., White, T.A., Sepe, A., Johnson, K.O., Stout, M.B., Giorgadze, N., Jensen, M.D., Lebrasseur, N.K., Tchkonia, T., Kirkland, J.L., Targeting senescent cells enhances adipogenesis and metabolic function in old age. eLife, 2015, 10.7554/eLife.12997.
58. Xu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E.R., Pirtskhalava, T., White, T.A., Johnson, K.O., Stout, M.B., Mezera, V., Giorgadze, N., Jensen, M.D., Lebrasseur, N.K., Kirkland, J.L., JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E6301–E6310.
59. Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., Ben-Porath, I., Krizhanovsky, V., Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat. Commun., 7, 2016, 11190.
60. Zhang, Y., Bokov, A., Gelfond, J., Soto, V., Ikeno, Y., Hubbard, G., Diaz, V., Sloane, L., Maslin, K., Treaster, S., Rendon, S., van Remmen, H., Ward, W., Javors, M., Richardson, A., Austad, S.N., Fischer, K., Rapamycin extends life and health in C57BL/6 mice. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 69 (2014), 119–130.
61. Zhu, Y., Armstrong, J.L., Tchkonia, T., Kirkland, J.L., Cellular senescence and the senescent secretory phenotype in age-related chronic diseases. Curr. Opin. Clin. Nutr. Metabol. Care 17 (2014), 324–328.
62. Zhu, Y., Doornebal, E.J., Pirtskhalava, T., Giorgadze, N., Wentworth, M., Fuhrmann-Stroissnigg, H., Niedernhofer, L.J., Robbins, P.D., Tchkonia, T., Kirkland, J.L., New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging 9 (2017), 955–963.
63. Zhu, Y., Tchkonia, T., Fuhrmann-Stroissnigg, H., Dai, H.M., Ling, Y.Y., Stout, M.B., Pirtskhalava, T., Giorgadze, N., Johnson, K.O., Giles, C.B., Wren, J.D., Niedernhofer, L.J., Robbins, P.D., KIRKLAND, J.L., Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 2016:15 (2015), 428–435 (Epub ahead of print Dec 29, 2015).
64. Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A., Ding, H., Giorgadze, N., Palmer, A.K., Ikeno, Y., Borden, G., Lenburg, M., O'Hara, S.P., Larusso, N.F., Miller, J.D., Roos, C.M., Verzosa, G.C., Lebrasseur, N.K., Wren, J.D., Farr, J.N., Khosla, S., Stout, M.B., Mcgowan, S.J., Fuhrmann-Stroissnigg, H., Gurkar, A.U., Zhao, J., Colangelo, D., Dorronsoro, A., Ling, Y.Y., Barghouthy, A.S., Navarro, D.C., Sano, T., Robbins, P.D., Niedernhofer, L.J., Kirkland, J.L., The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14 (2015), 644–658.